Eam Investors, LLC Next Cure, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$21.19 - $40.2 $412,887 - $783,297	-19,485 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$32.32 - $58.37 $414,407 - $748,420	-12,822 Reduced 39.69%	19,485 $722,000
Q4 2019 Feb 11, 2020	SELL	$25.0 - $92.22 $218,675 - $806,648	-8,747 Reduced 21.31%	32,307 $1.82 Million
Q3 2019 Nov 13, 2019	BUY	$15.73 - $41.6 $645,779 - $1.71 Million	41,054 New	41,054 $1.27 Million

14.6M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $17.2M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.